BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12716042)

  • 21. Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers.
    Behrens P; Mathiak M; Mangold E; Kirdorf S; Wellmann A; Fogt F; Rothe M; Florin A; Wernert N
    Int J Cancer; 2003 Nov; 107(2):183-8. PubMed ID: 12949792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study.
    Davidson B; Goldberg I; Kopolovic J; Gotlieb WH; Givant-Horwitz V; Nesland JM; Berner A; Ben-Baruch G; Bryne M; Reich R
    Clin Exp Metastasis; 2000; 18(6):501-7. PubMed ID: 11592307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
    Cowden Dahl KD; Zeineldin R; Hudson LG
    Mol Cancer Res; 2007 May; 5(5):413-21. PubMed ID: 17475671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
    Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I
    Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma].
    Xu FL; Li YL; Wang ZD; Feng YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):396-400. PubMed ID: 12974081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
    Davidson B; Reich R; Berner A; Givant-Horwitz V; Goldberg I; Risberg B; Kristensen GB; Trope CG; Bryne M; Kopolovic J; Nesland JM
    Eur J Cancer; 2001 Nov; 37(16):2040-9. PubMed ID: 11597382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
    Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
    Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture.
    Hultgårdh-Nilsson A; Lövdahl C; Blomgren K; Kallin B; Thyberg J
    Cardiovasc Res; 1997 May; 34(2):418-30. PubMed ID: 9205557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells.
    Barrett JM; Puglia MA; Singh G; Tozer RG
    Breast Cancer Res Treat; 2002 Apr; 72(3):227-32. PubMed ID: 12058964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells.
    Yan H; Qiu L; Xie X; Yang H; Liu Y; Lin X; Huang H
    Oncol Rep; 2017 Mar; 37(3):1412-1418. PubMed ID: 28184931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
    Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S
    Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.
    Shindoh M; Higashino F; Kaya M; Yasuda M; Funaoka K; Hanzawa M; Hida K; Kohgo T; Amemiya A; Yoshida K; Fujinaga K
    Am J Pathol; 1996 Mar; 148(3):693-700. PubMed ID: 8774124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
    Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J
    Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of heparanase, Mdm2, and erbB2 in ovarian cancer.
    Ginath S; Menczer J; Friedmann Y; Aingorn H; Aviv A; Tajima K; Dantes A; Glezerman M; Vlodavsky I; Amsterdam A
    Int J Oncol; 2001 Jun; 18(6):1133-44. PubMed ID: 11351242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.
    Wernert N; Raes MB; Lassalle P; Dehouck MP; Gosselin B; Vandenbunder B; Stehelin D
    Am J Pathol; 1992 Jan; 140(1):119-27. PubMed ID: 1370594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.